Antiphospholipid antibodies in critically ill patients

Antiphospholipid antibodies in critically ill patients

Antiphospholipid antibodies are responsible for a wide spectrum of clinical manifestations. Venous, arterial and microvascular thrombosis and severe catastrophic cases account for a large morbidly/mortality. Through the connection between the immune, inflammatory and hemostatic systems, it is possible that these antibodies may contribute to the development of organ dysfunction and are associate...

Antiphospholipid Antibodies and Multiple Organ Failure in Critically Ill Cancer Patients

OBJECTIVES To describe the clinical outcomes and thrombotic events in a series of critically ill cancer patients positive for antiphospholipid (aPL) antibodies. DESIGN Retrospective case series study. SETTING Medical-surgical oncologic intensive care unit (ICU). PATIENTS AND PARTICIPANTS Eighteen patients with SIRS/sepsis and multiple organ failure (MOF) and positive for aPL antibodies, i...

Nutritional Assessment in Critically Ill Patients

Background: Malnutrition is an important factor in the survival of critically ill patients. The purpose of the present study was to assess the nutritional status of patients in the intensive care unit (ICU) on the days of admission and discharge via a detailed nutritional assessment. Methods: Totally, 125 patients were followed up from admission to discharge at 8ICUs in Shiraz, Iran. The patien...

probiotics in critically ill patients

Prevalence of Antiphospholipid Antibodies in Syrian Patients with Thrombosis

Background: Antiphospholipid antibodies (aPL) are a heterogeneous family of anti-bodies associated with thrombosis and other complications. Objective: To study the prevalence of aPL in patients with thrombosis at Aleppo University Hospitals, Syria. Methods: One hundred and fifty-seven patients with venous and arterial thrombosis and 63 healthy controls were studied. Anticardiolipin antibodies (...